Sign in

CIK 0001593899 · Non-accelerated filer<br>Smaller reporting company

Atea Pharmaceuticals, Inc.

Sign in to watch
Ticker
AVIR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
MA
Entity type
operating
EIN
460574869
Phone
(857) 284-8891
Business address
225 FRANKLIN STREET, SUITE 2100, BOSTON, MA, 02110
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-18 Murphy Polly A. Director Purchase +6,100 $4.17 $25K 92,145
2025-05-18 Murphy Polly A. Director Purchase +6,100 $4.17 $25K 92,145
2025-01-16 BERGER FRANKLIN M Director Purchase +10,000 $3.36 $34K 476,897
2025-01-16 BERGER FRANKLIN M Director Purchase −10,000 $3.36 $34K 476,897
2025-01-15 BERGER FRANKLIN M Director Purchase +15,000 $3.19 $48K 466,897
2025-01-15 BERGER FRANKLIN M Director Purchase −15,000 $3.19 $48K 466,897
2021-12-20 Murphy Polly A. Director Purchase +12,000 $8.57 $103K 23,295
2020-11-03 Rock Springs Capital Management LP 10% owner Purchase +242,708 $24.00 $5.8M 1,654,724
2020-11-03 Rock Springs Capital Management LP 10% owner Purchase +7,292 $24.00 $175K 289,695
2020-11-03 Hack Andrew A. F. Director Purchase +250,000 $24.00 $6.0M 5,615,659
2020-11-03 BERGER FRANKLIN M Director Purchase +41,666 $24.00 $1000K 820,019

Page 1 of 1 · 11 trades